Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.13 trillion and total revenue of $110.17 billion.
Market Cap
1.13T
Revenue
110.17B
Profits
-39.66B
PE Ratio
n/a
Profit Margin
-36.00%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 110.97B | -2.35% | 985,766 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 76.85B | -2.47% | 751,395 | 14.34B |
| 3 | ARGX | argenx SE | 49.79B | -0.11% | 312,160 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.72B | 0.26% | 698,550 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 34.34B | -1.20% | 134,387 | 5.34B |
| 6 | INSM | Insmed Incorporated | 33.42B | -3.00% | 1,826,853 | 606.42M |
| 7 | RPRX | Royalty Pharma plc | 27.63B | -0.83% | 2,370,085 | 2.38B |
| 8 | BNTX | BioNTech SE | 24.15B | 3.83% | 1,000,721 | 3.37B |
| 9 | MRNA | Moderna, Inc. | 20.21B | -0.62% | 6,275,967 | 1.94B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.19B | -0.95% | 3,126,934 | 13.31M |
| 11 | INCY | Incyte Corporation | 19.12B | -0.92% | 1,146,786 | 5.14B |
| 12 | RVMD | Revolution Medicines, Inc. | 19.11B | 0.22% | 1,984,800 | - |
| 13 | GMAB | Genmab A/S | 17.25B | -0.11% | 1,472,483 | 3.72B |
| 14 | SMMT | Summit Therapeutics Inc. | 15.25B | 1.86% | 2,520,029 | - |
| 15 | ASND | Ascendis Pharma A/S | 14.78B | -1.01% | 687,205 | 845.52M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.46B | -1.23% | 1,075,821 | 502.08M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.42B | -1.65% | 1,581,559 | 943.71M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 11.96B | -1.99% | 904,085 | 4.27B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.92B | -0.89% | 294,610 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.50B | -2.51% | 2,945,425 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.49B | -3.14% | 1,540,870 | 3.22B |
| 22 | ABVX | ABIVAX Société Anonyme | 10.03B | 0.36% | 998,599 | 5.37M |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.12B | -1.65% | 1,670,522 | 1.09B |
| 24 | AXSM | Axsome Therapeutics, Inc. | 9.11B | -0.44% | 560,243 | 638.50M |
| 25 | PRAX | Praxis Precision Medicines, Inc. | 8.80B | -1.28% | 254,069 | 7.46M |
| 26 | PCVX | Vaxcyte, Inc. | 8.76B | -1.31% | 863,474 | - |
| 27 | TECH | Bio-Techne Corporation | 8.69B | -0.05% | 1,196,961 | 1.22B |
| 28 | NUVL | Nuvalent, Inc. | 8.08B | -1.77% | 412,760 | - |
| 29 | HALO | Halozyme Therapeutics, Inc. | 8.03B | 1.10% | 999,831 | 1.40B |
| 30 | CYTK | Cytokinetics, Incorporated | 8.01B | 0.65% | 1,224,407 | 88.04M |
| 31 | KRYS | Krystal Biotech, Inc. | 7.62B | 0.26% | 162,513 | 389.13M |
| 32 | IBRX | ImmunityBio, Inc. | 7.52B | -2.67% | 14,361,211 | 113.29M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.94B | -2.63% | 399,731 | 39.21M |
| 34 | BLTE | Belite Bio, Inc | 6.80B | -4.64% | 198,927 | - |
| 35 | ACLX | Arcellx, Inc. | 6.74B | 0.03% | 789,736 | 22.29M |
| 36 | APGE | Apogee Therapeutics, Inc. | 6.37B | -0.29% | 397,192 | - |
| 37 | PTGX | Protagonist Therapeutics, Inc. | 6.31B | -5.06% | 577,206 | 46.02M |
| 38 | CNTA | Centessa Pharmaceuticals plc | 6.11B | -0.70% | 1,262,501 | 15.00M |
| 39 | TERN | Terns Pharmaceuticals, Inc. | 6.08B | 0.13% | 4,977,712 | - |
| 40 | COGT | Cogent Biosciences, Inc. | 5.86B | -2.62% | 1,468,753 | - |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.76B | -2.02% | 379,088 | 189.76M |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 5.74B | -3.79% | 722,852 | 521.31M |
| 43 | SRRK | Scholar Rock Holding Corporation | 5.74B | 1.57% | 1,186,167 | - |
| 44 | CGON | CG Oncology, Inc. | 5.72B | -1.25% | 1,214,887 | 4.04M |
| 45 | PTCT | PTC Therapeutics, Inc. | 5.69B | -3.05% | 587,612 | 1.73B |
| 46 | CELC | Celcuity Inc. | 5.66B | -6.02% | 625,722 | - |
| 47 | XENE | Xenon Pharmaceuticals Inc. | 5.57B | -0.32% | 655,879 | 7.50M |
| 48 | ERAS | Erasca, Inc. | 5.29B | -2.02% | 3,067,503 | - |
| 49 | APLS | Apellis Pharmaceuticals, Inc. | 5.21B | 0.34% | 6,741,070 | 1.00B |
| 50 | CAI | Caris Life Sciences, Inc. | 5.10B | -5.99% | 2,720,224 | 812.03M |
| 51 | IMVT | Immunovant, Inc. | 4.99B | -4.48% | 1,212,255 | - |
| 52 | TGTX | TG Therapeutics, Inc. | 4.98B | -2.60% | 1,407,835 | 616.29M |
| 53 | CRSP | CRISPR Therapeutics AG | 4.92B | -0.97% | 871,550 | 3.51M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.75B | -2.06% | 481,108 | 2.04M |
| 55 | FOLD | Amicus Therapeutics, Inc. | 4.54B | -0.07% | 2,036,079 | 634.21M |
| 56 | CORT | Corcept Therapeutics Incorporated | 4.46B | -0.80% | 843,252 | 761.41M |
| 57 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.13B | -0.48% | 761,028 | 7.70M |
| 58 | LGND | Ligand Pharmaceuticals Incorporated | 4.09B | -0.35% | 277,346 | 268.09M |
| 59 | SYRE | Spyre Therapeutics, Inc. | 4.03B | -0.93% | 498,967 | - |
| 60 | NAMS | NewAmsterdam Pharma Company N.V. | 4.00B | -0.88% | 547,230 | 22.50M |
| 61 | VKTX | Viking Therapeutics, Inc. | 3.97B | -1.97% | 1,735,100 | - |
| 62 | GPCR | Structure Therapeutics Inc. | 3.86B | -1.14% | 1,239,752 | - |
| 63 | ACAD | ACADIA Pharmaceuticals Inc. | 3.71B | -3.68% | 849,255 | 1.07B |
| 64 | EWTX | Edgewise Therapeutics, Inc. | 3.52B | -2.09% | 599,327 | - |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.52B | 7.55% | 432,376 | 803.79M |
| 66 | LEGN | Legend Biotech Corporation | 3.36B | -0.22% | 2,182,518 | 1.03B |
| 67 | VERA | Vera Therapeutics, Inc. | 3.21B | 10.04% | 2,934,190 | - |
| 68 | TARS | Tarsus Pharmaceuticals, Inc. | 3.09B | 0.18% | 383,800 | 451.36M |
| 69 | DYN | Dyne Therapeutics, Inc. | 3.08B | -3.51% | 1,243,829 | - |
| 70 | DNLI | Denali Therapeutics Inc. | 3.05B | -0.31% | 1,127,297 | - |
| 71 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.05B | -2.58% | 1,276,710 | 588.99M |
| 72 | ARQT | Arcutis Biotherapeutics, Inc. | 3.00B | -1.47% | 894,690 | 376.07M |
| 73 | ORKA | Oruka Therapeutics, Inc. | 2.95B | -6.32% | 1,021,686 | - |
| 74 | ALMS | Alumis Inc. | 2.93B | 0.48% | 910,667 | 24.05M |
| 75 | TNGX | Tango Therapeutics, Inc. | 2.85B | -3.62% | 1,731,138 | 62.38M |
| 76 | RCUS | Arcus Biosciences, Inc. | 2.80B | -4.04% | 590,564 | 247.00M |
| 77 | BEAM | Beam Therapeutics Inc. | 2.72B | 4.18% | 2,003,584 | 139.74M |
| 78 | SLNO | Soleno Therapeutics, Inc. | 2.72B | 0.23% | 3,501,386 | 190.41M |
| 79 | ELVN | Enliven Therapeutics, Inc. | 2.71B | -0.59% | 1,124,516 | - |
| 80 | IDYA | IDEAYA Biosciences, Inc. | 2.68B | -1.61% | 1,474,449 | 218.71M |
| 81 | TVTX | Travere Therapeutics, Inc. | 2.68B | -7.89% | 2,809,196 | 490.73M |
| 82 | RLAY | Relay Therapeutics, Inc. | 2.67B | -0.40% | 2,786,428 | 15.36M |
| 83 | KOD | Kodiak Sciences Inc. | 2.66B | 1.77% | 738,508 | - |
| 84 | MANE | Veradermics, Incorporated | 2.57B | 14.70% | 631,967 | - |
| 85 | IRON | Disc Medicine, Inc. | 2.53B | -1.46% | 194,262 | - |
| 86 | CLDX | Celldex Therapeutics, Inc. | 2.53B | -4.10% | 696,117 | 1.55M |
| 87 | IMNM | Immunome, Inc. | 2.45B | -3.52% | 1,138,670 | 6.94M |
| 88 | ZLAB | Zai Lab Limited | 2.33B | -0.29% | 493,363 | 460.16M |
| 89 | ADMA | ADMA Biologics, Inc. | 2.31B | -2.41% | 3,878,805 | 510.17M |
| 90 | AAPG | Ascentage Pharma Group International | 2.31B | -2.13% | 623 | 82.08M |
| 91 | RARE | Ultragenyx Pharmaceutical Inc. | 2.29B | -2.55% | 1,551,091 | 673.00M |
| 92 | SRPT | Sarepta Therapeutics, Inc. | 2.22B | -4.72% | 1,993,617 | 2.20B |
| 93 | NKTR | Nektar Therapeutics | 2.22B | -0.45% | 445,758 | 55.23M |
| 94 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | -0.05% | 1,191,863 | 158.18M |
| 95 | MLYS | Mineralys Therapeutics, Inc. | 2.19B | -2.02% | 981,964 | - |
| 96 | SNDX | Syndax Pharmaceuticals, Inc. | 2.16B | -1.29% | 912,029 | 172.35M |
| 97 | DFTX | Definium Therapeutics, Inc. | 2.15B | 0.51% | 1,436,702 | - |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 2.10B | -1.25% | 938,318 | 283.06M |
| 99 | STOK | Stoke Therapeutics, Inc. | 2.03B | -2.33% | 358,027 | 184.42M |
| 100 | ANAB | AnaptysBio, Inc. | 2.02B | 2.28% | 460,117 | 234.60M |
| 101 | ADPT | Adaptive Biotechnologies Corporation | 1.97B | -4.55% | 3,309,911 | 276.98M |
| 102 | MESO | Mesoblast Limited | 1.94B | 3.09% | 200,067 | 65.38M |
| 103 | ZYME | Zymeworks Inc. | 1.94B | -3.77% | 532,512 | 105.97M |
| 104 | AGIO | Agios Pharmaceuticals, Inc. | 1.93B | - | 765,236 | 54.03M |
| 105 | OCUL | Ocular Therapeutix, Inc. | 1.91B | -5.48% | 3,124,454 | 51.95M |
| 106 | TYRA | Tyra Biosciences, Inc. | 1.90B | -3.90% | 875,338 | - |
| 107 | GLPG | Galapagos NV | 1.89B | -0.56% | 137,102 | 1.31B |
| 108 | PVLA | Palvella Therapeutics, Inc. | 1.82B | -2.37% | 178,027 | - |
| 109 | CAPR | Capricor Therapeutics, Inc. | 1.79B | -1.30% | 743,610 | 11.13M |
| 110 | INVA | Innoviva, Inc. | 1.76B | -1.82% | 859,009 | 411.33M |
| 111 | PHVS | Pharvaris N.V. | 1.74B | -1.63% | 140,320 | - |
| 112 | RXRX | Recursion Pharmaceuticals, Inc. | 1.73B | -0.91% | 8,605,067 | 74.68M |
| 113 | VCEL | Vericel Corporation | 1.72B | 0.33% | 239,626 | 276.26M |
| 114 | SION | Sionna Therapeutics, Inc. | 1.70B | -2.57% | 223,104 | - |
| 115 | TRVI | Trevi Therapeutics, Inc. | 1.69B | -0.83% | 973,534 | - |
| 116 | HRMY | Harmony Biosciences Holdings, Inc. | 1.67B | -0.93% | 560,699 | 868.45M |
| 117 | NRIX | Nurix Therapeutics, Inc. | 1.66B | -1.29% | 1,156,403 | 71.78M |
| 118 | RAPP | Rapport Therapeutics, Inc. | 1.63B | -0.15% | 166,425 | - |
| 119 | OCS | Oculis Holding AG | 1.62B | 0.40% | 133,486 | 1.51M |
| 120 | NTLA | Intellia Therapeutics, Inc. | 1.59B | -2.46% | 1,809,235 | 67.67M |
| 121 | NUVB | Nuvation Bio Inc. | 1.58B | -0.65% | 3,566,606 | 62.90M |
| 122 | IMCR | Immunocore Holdings plc | 1.57B | -2.39% | 268,469 | 400.02M |
| 123 | DMRA | Damora Therapeutics, Inc. | 1.56B | -3.26% | 287,217 | - |
| 124 | VRDN | Viridian Therapeutics, Inc. | 1.53B | -2.80% | 2,407,801 | 70.85M |
| 125 | IOVA | Iovance Biotherapeutics, Inc. | 1.52B | -7.73% | 44,592,905 | 263.50M |
| 126 | VIR | Vir Biotechnology, Inc. | 1.52B | -3.36% | 1,408,298 | 68.56M |
| 127 | ARDX | Ardelyx, Inc. | 1.52B | 0.82% | 3,478,390 | 407.32M |
| 128 | MBX | MBX Biosciences, Inc. | 1.47B | -5.66% | 284,254 | - |
| 129 | PGEN | Precigen, Inc. | 1.47B | -2.58% | 2,826,265 | 9.68M |
| 130 | NBTX | Nanobiotix S.A. | 1.46B | -0.57% | 46,125 | 38.27M |
| 131 | GENB | Generate Biomedicines, Inc. | 1.45B | -1.04% | 345,915 | 31.89M |
| 132 | SVRA | Savara Inc. | 1.43B | -3.58% | 1,807,982 | - |
| 133 | OLMA | Olema Pharmaceuticals, Inc. | 1.40B | -3.25% | 1,212,335 | - |
| 134 | GLUE | Monte Rosa Therapeutics, Inc. | 1.40B | -3.16% | 711,592 | 123.67M |
| 135 | IMTX | Immatics N.V. | 1.40B | -2.16% | 203,529 | 56.67M |
| 136 | BCAX | Bicara Therapeutics Inc. | 1.38B | -3.91% | 483,571 | - |
| 137 | BHVN | Biohaven Ltd. | 1.38B | -2.34% | 1,350,167 | - |
| 138 | WVE | Wave Life Sciences Ltd. | 1.35B | 0.28% | 1,865,736 | 42.73M |
| 139 | ATAI | AtaiBeckley Inc. | 1.33B | -1.62% | 2,295,603 | 4.09M |
| 140 | MAZE | Maze Therapeutics, Inc. | 1.33B | -4.27% | 1,052,356 | 2.50M |
| 141 | NVAX | Novavax, Inc. | 1.32B | -4.92% | 3,450,124 | 1.12B |
| 142 | TSHA | Taysha Gene Therapies, Inc. | 1.29B | -3.02% | 1,574,509 | 9.77M |
| 143 | MLTX | MoonLake Immunotherapeutics | 1.29B | -7.47% | 1,249,946 | - |
| 144 | CRVS | Corvus Pharmaceuticals, Inc. | 1.27B | -3.64% | 547,225 | - |
| 145 | PHAR | Pharming Group N.V. | 1.22B | 0.65% | 8,324 | 376.13M |
| 146 | DBVT | DBV Technologies S.A. | 1.22B | -3.79% | 181,986 | 5.64M |
| 147 | ZBIO | Zenas BioPharma, Inc. | 1.22B | -3.95% | 384,653 | 10.00M |
| 148 | EYPT | EyePoint, Inc. | 1.18B | -0.28% | 742,028 | 31.37M |
| 149 | MPLT | MapLight Therapeutics, Inc. | 1.18B | -9.11% | 436,599 | - |
| 150 | AVBP | ArriVent BioPharma, Inc. | 1.13B | -6.57% | 337,620 | - |
| 151 | INBX | Inhibrx Biosciences, Inc. | 1.10B | -0.63% | 315,440 | 1.30M |
| 152 | ABCL | AbCellera Biologics Inc. | 1.07B | 2.91% | 2,409,495 | 75.13M |
| 153 | GERN | Geron Corporation | 1.07B | -5.11% | 16,565,452 | 183.88M |
| 154 | URGN | UroGen Pharma Ltd. | 1.05B | 5.07% | 1,067,911 | 109.79M |
| 155 | SEPN | Septerna, Inc. | 1.04B | -7.01% | 629,068 | 45.95M |
| 156 | ORIC | ORIC Pharmaceuticals, Inc. | 1.02B | -2.22% | 2,103,875 | - |
| 157 | IVA | Inventiva S.A. | 1.01B | -4.36% | 728,288 | 9.31M |
| 158 | XERS | Xeris Biopharma Holdings, Inc. | 1.01B | -2.66% | 942,078 | 291.85M |
| 159 | PHAT | Phathom Pharmaceuticals, Inc. | 1.00B | -0.08% | 1,441,312 | 175.11M |
| 160 | KALV | KalVista Pharmaceuticals, Inc. | 993.20M | -2.81% | 629,973 | 73.62M |
| 161 | GHRS | GH Research PLC | 975.10M | 2.95% | 123,286 | - |
| 162 | QURE | uniQure N.V. | 961.70M | -5.64% | 3,282,729 | 16.10M |
| 163 | CTMX | CytomX Therapeutics, Inc. | 949.02M | 3.54% | 3,199,349 | 76.20M |
| 164 | ANNX | Annexon, Inc. | 938.77M | -4.72% | 2,145,828 | - |
| 165 | AKTS | Aktis Oncology, Inc. | 933.06M | -4.47% | 263,903 | 6.50M |
| 166 | CMPX | Compass Therapeutics, Inc. | 931.05M | -5.14% | 3,158,300 | 850.00K |
| 167 | EVMN | Evommune, Inc. | 918.83M | -10.96% | 357,455 | 13.00M |
| 168 | XNCR | Xencor, Inc. | 910.87M | -0.88% | 530,478 | 125.58M |
| 169 | JANX | Janux Therapeutics, Inc. | 908.22M | 2.75% | 957,407 | 10.00M |
| 170 | JBIO | Jade Biosciences, Inc. | 882.27M | -1.87% | 654,462 | - |
| 171 | CGEM | Cullinan Therapeutics, Inc. | 880.05M | -4.40% | 388,330 | - |
| 172 | FTRE | Fortrea Holdings Inc. | 858.33M | -2.24% | 591,893 | 2.72B |
| 173 | SLS | SELLAS Life Sciences Group, Inc. | 854.81M | -5.74% | 3,964,916 | - |
| 174 | TBPH | Theravance Biopharma, Inc. | 841.91M | -1.21% | 361,592 | 107.46M |
| 175 | VOR | Vor Biopharma Inc. | 838.25M | -0.83% | 525,911 | - |
| 176 | OMER | Omeros Corporation | 827.24M | -3.53% | 970,357 | - |
| 177 | SANA | Sana Biotechnology, Inc. | 824.62M | -0.96% | 1,380,042 | - |
| 178 | DRUG | Bright Minds Biosciences Inc. | 818.66M | -2.75% | 159,256 | - |
| 179 | ABUS | Arbutus Biopharma Corporation | 811.23M | -3.49% | 2,674,263 | 14.08M |
| 180 | SPRY | ARS Pharmaceuticals, Inc. | 799.34M | -2.66% | 722,348 | 84.28M |
| 181 | MNKD | MannKind Corporation | 793.61M | 0.39% | 3,084,436 | 348.97M |
| 182 | MRVI | Maravai LifeSciences Holdings, Inc. | 789.20M | -1.29% | 983,615 | 185.74M |
| 183 | SLDB | Solid Biosciences Inc. | 789.10M | -0.99% | 647,589 | - |
| 184 | KURA | Kura Oncology, Inc. | 765.82M | -2.03% | 880,088 | 67.48M |
| 185 | RLMD | Relmada Therapeutics, Inc. | 764.64M | -4.20% | 1,764,086 | - |
| 186 | DSGN | Design Therapeutics, Inc. | 749.93M | -2.64% | 193,932 | - |
| 187 | MGTX | MeiraGTx Holdings plc | 730.57M | -3.96% | 518,060 | 81.39M |
| 188 | LXRX | Lexicon Pharmaceuticals, Inc. | 728.73M | -2.27% | 1,367,759 | 49.80M |
| 189 | ANRO | Alto Neuroscience, Inc. | 727.72M | 1.70% | 193,407 | - |
| 190 | TENX | Tenax Therapeutics, Inc. | 725.58M | -3.58% | 198,101 | - |
| 191 | SGP | SpyGlass Pharma, Inc. | 693.60M | -2.21% | 82,392 | - |
| 192 | ARVN | Arvinas, Inc. | 692.06M | -3.13% | 490,193 | 262.60M |
| 193 | GYRE | Gyre Therapeutics, Inc. | 674.81M | 2.07% | 47,005 | 116.59M |
| 194 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 672.28M | -5.19% | 290,236 | - |
| 195 | ALLO | Allogene Therapeutics, Inc. | 663.08M | -6.53% | 8,398,958 | 22.00K |
| 196 | FBRX | Forte Biosciences, Inc. | 658.58M | 3.51% | 934,669 | - |
| 197 | DRTS | Alpha Tau Medical Ltd. | 641.59M | -0.82% | 126,123 | - |
| 198 | LBRX | LB Pharmaceuticals Inc | 615.78M | -7.42% | 590,872 | - |
| 199 | PRME | Prime Medicine, Inc. | 607.38M | -2.28% | 1,688,113 | 4.63M |
| 200 | CBIO | Crescent Biopharma, Inc. | 603.50M | -4.87% | 154,596 | 10.84M |
| 201 | OCGN | Ocugen, Inc. | 594.70M | -5.88% | 6,490,096 | 4.41M |
| 202 | PROK | ProKidney Corp. | 588.74M | 2.63% | 1,750,730 | 893.00K |
| 203 | TECX | Tectonic Therapeutic, Inc. | 576.82M | -1.27% | 98,722 | - |
| 204 | MDXG | MiMedx Group, Inc. | 574.95M | -3.97% | 966,154 | 418.63M |
| 205 | CRMD | CorMedix Inc. | 572.32M | -1.63% | 636,732 | 311.71M |
| 206 | UPB | Upstream Bio, Inc. | 570.87M | 0.67% | 733,120 | 2.85M |
| 207 | PRTA | Prothena Corporation plc | 565.25M | -0.76% | 319,029 | 9.68M |
| 208 | ACRS | Aclaris Therapeutics, Inc. | 561.54M | -0.98% | 617,360 | 7.83M |
| 209 | ZVRA | Zevra Therapeutics, Inc. | 556.00M | -2.47% | 690,827 | 106.47M |
| 210 | VALN | Valneva SE | 545.59M | 0.49% | 13,504 | 205.07M |
| 211 | KYTX | Kyverna Therapeutics, Inc. | 541.07M | -6.58% | 694,818 | - |
| 212 | RIGL | Rigel Pharmaceuticals, Inc. | 539.42M | -4.29% | 782,384 | 294.28M |
| 213 | ZURA | Zura Bio Limited | 536.08M | 0.89% | 500,372 | - |
| 214 | LYEL | Lyell Immunopharma, Inc. | 522.32M | -6.12% | 108,297 | 36.00K |
| 215 | AGMB | AgomAb Therapeutics NV | 513.69M | 3.23% | 144,482 | - |
| 216 | LRMR | Larimar Therapeutics, Inc. | 503.83M | -4.72% | 1,898,790 | - |
| 217 | FULC | Fulcrum Therapeutics, Inc. | 502.83M | -4.55% | 1,054,782 | 80.00M |
| 218 | FDMT | 4D Molecular Therapeutics, Inc. | 500.82M | -0.30% | 900,753 | 85.21M |
| 219 | IVVD | Invivyd, Inc. | 497.73M | -1.12% | 16,684,859 | 53.43M |
| 220 | STTK | Shattuck Labs, Inc. | 495.22M | -6.49% | 471,950 | 1.00M |
| 221 | IMMX | Immix Biopharma, Inc. | 490.89M | -5.03% | 399,412 | - |
| 222 | EIKN | Eikon Therapeutics, Inc. | 487.25M | -0.11% | 706,087 | - |
| 223 | TRDA | Entrada Therapeutics, Inc. | 486.00M | -3.91% | 213,004 | 25.42M |
| 224 | ENGN | enGene Holdings Inc. | 482.32M | -0.96% | 95,288 | - |
| 225 | CTNM | Contineum Therapeutics, Inc. | 480.51M | 0.31% | 154,316 | - |
| 226 | ADCT | ADC Therapeutics SA | 475.15M | -0.53% | 644,124 | 81.36M |
| 227 | ZNTL | Zentalis Pharmaceuticals, Inc. | 468.85M | 49.55% | 46,332,589 | 26.87M |
| 228 | VSTM | Verastem, Inc. | 466.40M | -5.01% | 1,600,868 | 30.91M |
| 229 | ABSI | Absci Corporation | 456.00M | 1.02% | 3,851,848 | 2.80M |
| 230 | RGNX | REGENXBIO Inc. | 454.23M | -1.79% | 479,220 | 170.44M |
| 231 | VTVT | vTv Therapeutics Inc. | 453.69M | -1.98% | 38,637 | 17.00K |
| 232 | AVIR | Atea Pharmaceuticals, Inc. | 451.74M | -2.91% | 271,320 | - |
| 233 | ASMB | Assembly Biosciences, Inc. | 450.82M | -4.79% | 138,898 | 72.30M |
| 234 | LXEO | Lexeo Therapeutics, Inc. | 443.04M | -7.00% | 706,418 | - |
| 235 | YDES | YD Bio Limited | 440.20M | 8.30% | 9,099 | 510.36K |
| 236 | XOMA | XOMA Royalty Corporation | 437.78M | 0.08% | 84,863 | 52.15M |
| 237 | AURA | Aura Biosciences, Inc. | 436.22M | 0.29% | 223,970 | - |
| 238 | STRO | Sutro Biopharma, Inc. | 428.43M | -3.36% | 202,122 | 102.48M |
| 239 | VNDA | Vanda Pharmaceuticals Inc. | 426.76M | -1.50% | 854,484 | 216.11M |
| 240 | EPRX | Eupraxia Pharmaceuticals Inc. | 423.45M | -3.11% | 63,679 | - |
| 241 | ALT | Altimmune, Inc. | 421.54M | -4.14% | 1,936,609 | 41.00K |
| 242 | ANL | Adlai Nortye Ltd. | 411.81M | -7.00% | 377,440 | 5.40M |
| 243 | ENTA | Enanta Pharmaceuticals, Inc. | 409.46M | 1.15% | 227,552 | 66.98M |
| 244 | ARMP | Armata Pharmaceuticals, Inc. | 407.36M | -3.56% | 17,787 | 4.90M |
| 245 | IPSC | Century Therapeutics, Inc. | 404.38M | -0.44% | 910,557 | 109.16M |
| 246 | CLYM | Climb Bio, Inc. | 401.73M | 4.47% | 827,963 | - |
| 247 | PRTC | PureTech Health plc | 398.08M | 0.36% | 4,485 | 6.39M |
| 248 | AUTL | Autolus Therapeutics plc | 396.55M | 1.36% | 1,519,558 | 75.39M |
| 249 | PBYI | Puma Biotechnology, Inc. | 395.82M | -0.26% | 317,251 | 228.37M |
| 250 | REPL | Replimune Group, Inc. | 393.05M | -19.46% | 8,192,375 | - |
| 251 | BNTC | Benitec Biopharma Inc. | 391.19M | 3.72% | 144,466 | - |
| 252 | IRD | Opus Genetics, Inc. | 381.36M | -2.55% | 869,916 | 14.20M |
| 253 | RCKT | Rocket Pharmaceuticals, Inc. | 380.84M | -3.06% | 2,334,293 | - |
| 254 | RZLT | Rezolute, Inc. | 378.09M | -0.27% | 2,467,543 | - |
| 255 | DNA | Ginkgo Bioworks Holdings, Inc. | 375.44M | 0.31% | 748,058 | 170.16M |
| 256 | MNPR | Monopar Therapeutics Inc. | 375.30M | -3.18% | 202,624 | - |
| 257 | NAUT | Nautilus Biotechnology, Inc. | 373.37M | -2.96% | 393,152 | - |
| 258 | XFOR | X4 Pharmaceuticals, Inc. | 372.77M | 0.74% | 235,122 | 35.11M |
| 259 | NMRA | Neumora Therapeutics, Inc. | 371.36M | -1.92% | 765,546 | - |
| 260 | LCTX | Lineage Cell Therapeutics, Inc. | 368.65M | -0.67% | 850,680 | 14.56M |
| 261 | OVID | Ovid Therapeutics Inc. | 362.66M | -4.51% | 3,442,302 | 7.25M |
| 262 | NAGE | Niagen Bioscience, Inc. | 361.11M | 0.45% | 401,255 | 129.42M |
| 263 | GLSI | Greenwich LifeSciences, Inc. | 357.17M | -0.15% | 81,813 | - |
| 264 | IMRX | Immuneering Corporation | 356.88M | -2.47% | 573,522 | - |
| 265 | CADL | Candel Therapeutics, Inc. | 353.78M | 0.63% | 591,592 | - |
| 266 | CABA | Cabaletta Bio, Inc. | 348.44M | -1.26% | 1,180,440 | - |
| 267 | BCYC | Bicycle Therapeutics plc | 344.35M | -0.60% | 693,128 | 72.59M |
| 268 | PRLD | Prelude Therapeutics Incorporated | 336.74M | -7.27% | 194,724 | 12.14M |
| 269 | NGEN | NervGen Pharma Corp. | 327.77M | -3.80% | 263,480 | - |
| 270 | ACIU | AC Immune SA | 325.38M | -3.53% | 307,054 | 4.51M |
| 271 | SRZN | Surrozen, Inc. | 323.93M | 2.73% | 215,996 | 3.48M |
| 272 | DMAC | DiaMedica Therapeutics Inc. | 322.76M | -3.07% | 372,554 | - |
| 273 | NGNE | Neurogene Inc. | 317.40M | -4.84% | 120,118 | 925.00K |
| 274 | AVTX | Avalo Therapeutics, Inc. | 311.29M | -3.87% | 726,124 | 59.00K |
| 275 | PALI | Palisade Bio, Inc. | 304.71M | -8.08% | 5,108,887 | - |
| 276 | IKT | Inhibikase Therapeutics, Inc. | 289.72M | 0.59% | 864,320 | 1.00 |
| 277 | EDIT | Editas Medicine, Inc. | 287.74M | 1.73% | 1,593,923 | 40.52M |
| 278 | LENZ | LENZ Therapeutics, Inc. | 284.38M | -2.37% | 530,960 | 19.09M |
| 279 | ABEO | Abeona Therapeutics Inc. | 280.11M | -4.10% | 3,278,034 | 5.82M |
| 280 | AVXL | Anavex Life Sciences Corp. | 273.38M | -3.28% | 1,035,287 | - |
| 281 | NBP | NovaBridge Biosciences | 272.93M | -2.88% | 339,250 | - |
| 282 | CLLS | Cellectis S.A. | 271.65M | 2.57% | 10,567 | 79.59M |
| 283 | SLN | Silence Therapeutics plc | 270.65M | -1.21% | 923,315 | 559.00K |
| 284 | ALEC | Alector, Inc. | 270.39M | 2.08% | 572,970 | 21.05M |
| 285 | FHTX | Foghorn Therapeutics Inc. | 269.43M | -4.18% | 160,868 | 30.91M |
| 286 | PLYX | Polaryx Therapeutics, Inc. | 268.91M | -1.39% | 99,050 | - |
| 287 | TARA | Protara Therapeutics, Inc. | 268.26M | -6.59% | 686,816 | - |
| 288 | SABS | SAB Biotherapeutics, Inc. | 263.53M | -2.09% | 197,594 | 114.70K |
| 289 | HELP | Cybin Inc. | 261.19M | -0.38% | 415,227 | - |
| 290 | CHRS | Coherus Oncology, Inc. | 251.82M | 1.82% | 556,774 | 42.17M |
| 291 | ADAG | Adagene Inc. | 251.08M | -1.17% | 298,588 | 7.67M |
| 292 | MIST | Milestone Pharmaceuticals Inc. | 247.75M | 0.50% | 3,652,363 | 1.55M |
| 293 | CCCC | C4 Therapeutics, Inc. | 247.36M | -10.42% | 3,944,489 | 35.95M |
| 294 | SLGL | Sol-Gel Technologies Ltd. | 244.72M | 5.25% | 73,168 | 19.39M |
| 295 | CGEN | Compugen Ltd. | 243.95M | 4.03% | 765,595 | 72.76M |
| 296 | OBIO | Orchestra BioMed Holdings, Inc. | 241.69M | -2.36% | 106,096 | 33.48M |
| 297 | NERV | Minerva Neurosciences, Inc. | 238.44M | -8.47% | 309,520 | - |
| 298 | ARCT | Arcturus Therapeutics Holdings Inc. | 237.62M | 1.70% | 372,175 | 82.03M |
| 299 | ELDN | Eledon Pharmaceuticals, Inc. | 235.50M | - | 971,056 | - |
| 300 | CAMP | Camp4 Therapeutics Corporation | 233.12M | - | 60,986 | 3.50M |
| 301 | MDWD | MediWound Ltd. | 229.41M | 0.45% | 80,508 | 16.96M |
| 302 | MGNX | MacroGenics, Inc. | 228.80M | 4.65% | 2,060,185 | 149.50M |
| 303 | CNTX | Context Therapeutics Inc. | 228.78M | -3.86% | 519,411 | - |
| 304 | ENLV | Enlivex Ltd. | 228.24M | 1.25% | 177,093 | - |
| 305 | ALXO | ALX Oncology Holdings Inc. | 223.73M | 2.06% | 2,595,932 | - |
| 306 | VYGR | Voyager Therapeutics, Inc. | 222.90M | -5.56% | 785,077 | 40.37M |
| 307 | KROS | Keros Therapeutics, Inc. | 220.93M | -10.29% | 334,806 | 244.06M |
| 308 | NVCT | Nuvectis Pharma, Inc. | 217.76M | 0.74% | 27,117 | - |
| 309 | OABI | OmniAb, Inc. | 212.83M | -2.00% | 310,331 | 18.67M |
| 310 | CDXS | Codexis, Inc. | 203.55M | -6.67% | 1,708,557 | 70.39M |
| 311 | FENC | Fennec Pharmaceuticals Inc. | 200.30M | -9.22% | 322,770 | 44.64M |
| 312 | PRQR | ProQR Therapeutics N.V. | 194.92M | -6.57% | 430,193 | 19.19M |
| 313 | MENS | Jyong Biotech Ltd. | 191.48M | -7.09% | 111,352 | - |
| 314 | ELTX | Elicio Therapeutics, Inc. | 186.72M | -1.36% | 48,599 | - |
| 315 | CRBU | Caribou Biosciences, Inc. | 186.51M | -1.53% | 821,295 | 11.16M |
| 316 | ACHV | Achieve Life Sciences, Inc. | 185.81M | 5.12% | 570,443 | - |
| 317 | PLX | Protalix BioTherapeutics, Inc. | 185.31M | 0.88% | 394,186 | 52.74M |
| 318 | KRRO | Korro Bio, Inc. | 182.88M | -3.06% | 80,656 | 6.39M |
| 319 | KPTI | Karyopharm Therapeutics Inc. | 180.35M | -1.96% | 451,541 | 146.07M |
| 320 | ABOS | Acumen Pharmaceuticals, Inc. | 178.37M | -1.59% | 262,673 | - |
| 321 | TNXP | Tonix Pharmaceuticals Holding Corp. | 177.28M | -4.00% | 439,041 | 13.11M |
| 322 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 173.82M | -5.04% | 225,148 | - |
| 323 | SGMT | Sagimet Biosciences Inc. | 172.70M | -6.03% | 392,884 | - |
| 324 | DTIL | Precision BioSciences, Inc. | 172.11M | 0.91% | 423,302 | 34.26M |
| 325 | CNTN | Canton Strategic Holdings, Inc. | 169.12M | -12.21% | 1,541,381 | - |
| 326 | ARTV | Artiva Biotherapeutics, Inc. | 168.32M | 0.15% | 125,885 | 251.00K |
| 327 | UNCY | Unicycive Therapeutics, Inc. | 167.33M | -0.30% | 276,476 | - |
| 328 | HRTX | Heron Therapeutics, Inc. | 160.82M | 4.10% | 2,044,175 | 154.90M |
| 329 | MOLN | Molecular Partners AG | 160.39M | 2.17% | 228 | 856.30K |
| 330 | WHWK | Whitehawk Therapeutics, Inc. | 160.00M | -4.51% | 68,233 | 7.15M |
| 331 | CNTB | Connect Biopharma Holdings Limited | 159.39M | 1.44% | 201,431 | 64.00K |
| 332 | RNAC | Cartesian Therapeutics, Inc. | 158.52M | -3.24% | 174,861 | 2.80M |
| 333 | NKTX | Nkarta, Inc. | 154.70M | -7.26% | 795,099 | - |
| 334 | SPRO | Spero Therapeutics, Inc. | 154.57M | -3.96% | 786,941 | 66.80M |
| 335 | IMUX | Immunic, Inc. | 152.64M | -9.30% | 1,997,998 | - |
| 336 | AGEN | Agenus Inc. | 152.06M | -11.01% | 2,104,057 | 114.20M |
| 337 | GALT | Galectin Therapeutics Inc. | 151.40M | -5.35% | 201,601 | - |
| 338 | TLSA | Tiziana Life Sciences Ltd | 150.60M | -6.35% | 341,051 | - |
| 339 | TNYA | Tenaya Therapeutics, Inc. | 149.73M | -6.76% | 4,146,092 | - |
| 340 | BDTX | Black Diamond Therapeutics, Inc. | 146.66M | -0.78% | 876,608 | 70.00M |
| 341 | KLRS | Kalaris Therapeutics, Inc. | 144.45M | 3.79% | 63,402 | - |
| 342 | HURA | TuHURA Biosciences, Inc. | 144.32M | 15.82% | 1,932,047 | - |
| 343 | FATE | Fate Therapeutics, Inc. | 144.17M | -2.36% | 1,215,994 | 6.65M |
| 344 | HUMA | Humacyte, Inc. | 143.29M | 6.33% | 4,666,049 | 2.04M |
| 345 | ORMP | Oramed Pharmaceuticals Inc. | 142.78M | 0.28% | 55,699 | 2.00M |
| 346 | BMEA | Biomea Fusion, Inc. | 135.20M | 1.08% | 1,129,719 | - |
| 347 | ACOG | Alpha Cognition Inc. | 131.30M | -5.49% | 48,268 | 10.22M |
| 348 | NTHI | NeOnc Technologies Holdings, Inc. | 129.51M | 6.25% | 97,270 | 39.99K |
| 349 | IPHA | Innate Pharma S.A. | 127.93M | -2.76% | 46,325 | 10.57M |
| 350 | CBUS | Cibus, Inc. | 115.02M | 19.84% | 1,605,733 | 3.64M |
| 351 | EQ | Equillium, Inc. | 113.81M | -5.76% | 244,763 | 4.39M |
| 352 | PEPG | PepGen Inc. | 113.35M | 1.86% | 1,040,126 | - |
| 353 | PMN | ProMIS Neurosciences, Inc. | 112.99M | 0.80% | 35,477 | - |
| 354 | GNLX | Genelux Corporation | 112.71M | -0.78% | 166,396 | 8.00K |
| 355 | CRDF | Cardiff Oncology, Inc. | 108.02M | -5.39% | 697,868 | 593.00K |
| 356 | ONCY | Oncolytics Biotech Inc. | 108.00M | -10.58% | 2,054,649 | - |
| 357 | ALDX | Aldeyra Therapeutics, Inc. | 107.13M | 11.95% | 2,256,576 | - |
| 358 | PYXS | Pyxis Oncology, Inc. | 106.81M | 5.59% | 727,517 | 13.86M |
| 359 | ANTX | AN2 Therapeutics, Inc. | 106.75M | -2.62% | 573,486 | - |
| 360 | SGMO | Sangamo Therapeutics, Inc. | 104.07M | -4.09% | 4,418,554 | 39.55M |
| 361 | KZIA | Kazia Therapeutics Limited | 100.79M | -3.08% | 77,243 | 1.27M |
| 362 | TTRX | Turn Therapeutics Inc. | 99.79M | -4.56% | 65,966 | - |
| 363 | EXOZ | eXoZymes, Inc. | 99.20M | 2.63% | 18,099 | -700.00 |
| 364 | COYA | Coya Therapeutics, Inc. | 97.82M | -7.95% | 156,636 | 7.95M |
| 365 | GOSS | Gossamer Bio, Inc. | 96.11M | 10.20% | 11,775,555 | 48.47M |
| 366 | SEER | Seer, Inc. | 95.35M | -0.59% | 109,451 | 16.58M |
| 367 | LONA | LeonaBio, Inc. | 91.02M | 1.57% | 45,192 | - |
| 368 | ANIX | Anixa Biosciences, Inc. | 90.19M | -1.82% | 171,166 | - |
| 369 | VANI | Vivani Medical, Inc. | 88.03M | - | 115,233 | - |
| 370 | VRCA | Verrica Pharmaceuticals Inc. | 87.78M | -12.35% | 169,072 | 35.58M |
| 371 | SPRB | Spruce Biosciences, Inc. | 87.30M | -3.61% | 82,290 | 697.00K |
| 372 | INO | Inovio Pharmaceuticals, Inc. | 86.85M | 0.95% | 2,510,016 | 65.34K |
| 373 | AARD | Aardvark Therapeutics, Inc. | 85.96M | 1.03% | 115,743 | - |
| 374 | PYPD | PolyPid Ltd. | 82.25M | -1.37% | 43,311 | - |
| 375 | ATYR | aTyr Pharma, Inc. | 81.62M | 10.99% | 980,599 | 190.00K |
| 376 | CGTX | Cognition Therapeutics, Inc. | 80.83M | 5.16% | 555,016 | - |
| 377 | CSBR | Champions Oncology, Inc. | 79.85M | - | 30,244 | 57.95M |
| 378 | MCRB | Seres Therapeutics, Inc. | 79.76M | -4.36% | 51,679 | 789.00K |
| 379 | PLRX | Pliant Therapeutics, Inc. | 79.25M | -5.19% | 546,162 | - |
| 380 | OKYO | OKYO Pharma Limited | 79.24M | -4.43% | 177,322 | - |
| 381 | FLNA | Filana Therapeutics, Inc. | 79.22M | -4.65% | 177,521 | - |
| 382 | ESLA | Estrella Immunopharma, Inc. | 78.50M | -0.54% | 94,532 | - |
| 383 | MAIA | MAIA Biotechnology, Inc. | 77.66M | 6.67% | 516,715 | - |
| 384 | NRXS | NeurAxis, Inc. | 76.52M | -5.66% | 167,509 | 3.57M |
| 385 | GANX | Gain Therapeutics, Inc. | 76.04M | -2.17% | 411,051 | - |
| 386 | PTHS | Pelthos Therapeutics Inc. | 75.77M | - | 956 | 16.80M |
| 387 | FBIO | Fortress Biotech, Inc. | 75.68M | -2.08% | 322,518 | 63.26M |
| 388 | IBIO | iBio, Inc. | 74.61M | -1.82% | 513,920 | 300.00K |
| 389 | COEP | Coeptis Therapeutics Holdings, Inc. | 74.37M | -5.31% | 18,519 | 1.36M |
| 390 | IBO | Impact BioMedical Inc. | 74.16M | -3.13% | 69,061 | 32.00K |
| 391 | QTTB | Q32 Bio Inc. | 73.88M | 2.64% | 252,167 | 53.74M |
| 392 | RANI | Rani Therapeutics Holdings, Inc. | 73.79M | -5.13% | 1,182,939 | 1.63M |
| 393 | MNOV | MediciNova, Inc. | 73.34M | 4.58% | 59,332 | 409.66K |
| 394 | NRXP | NRx Pharmaceuticals, Inc. | 73.34M | -1.77% | 477,456 | 1.23M |
| 395 | GUTS | Fractyl Health, Inc. | 72.98M | -2.09% | 434,145 | 3.00K |
| 396 | ACET | Adicet Bio, Inc. | 72.66M | -1.46% | 61,708 | - |
| 397 | IFRX | InflaRx N.V. | 72.29M | -2.91% | 220,430 | 34.44K |
| 398 | BYSI | BeyondSpring Inc. | 71.55M | -1.69% | 25,019 | 1.88M |
| 399 | XBIT | XBiotech Inc. | 71.04M | - | 33,845 | - |
| 400 | PMVP | PMV Pharmaceuticals, Inc. | 70.39M | -0.75% | 260,468 | - |
| 401 | ATHE | Alterity Therapeutics Limited | 69.37M | -3.38% | 5,977 | 4.43M |
| 402 | CING | Cingulate Inc. | 66.98M | -3.36% | 300,609 | - |
| 403 | DWTX | Dogwood Therapeutics, Inc. | 66.47M | 0.51% | 51,954 | - |
| 404 | ICCC | ImmuCell Corporation | 64.01M | -1.60% | 17,140 | 27.64M |
| 405 | TCRX | TScan Therapeutics, Inc. | 63.11M | -0.94% | 1,119,651 | 10.33M |
| 406 | ENTX | Entera Bio Ltd. | 62.62M | -1.74% | 28,120 | 42.00K |
| 407 | ACRV | Acrivon Therapeutics, Inc. | 60.44M | 0.65% | 415,695 | - |
| 408 | PDSB | PDS Biotechnology Corporation | 60.28M | 0.93% | 996,570 | - |
| 409 | OKUR | OnKure Therapeutics, Inc. | 58.80M | 0.47% | 127,814 | - |
| 410 | GRCE | Grace Therapeutics, Inc. | 55.55M | -0.83% | 415,772 | - |
| 411 | RADX | Radiopharm Theranostics Limited | 55.26M | -0.21% | 41,233 | 10.86M |
| 412 | TIL | Instil Bio, Inc. | 55.00M | -4.36% | 23,397 | - |
| 413 | IMA | ImageneBio, Inc. | 54.83M | 3.20% | 4,697 | 800.00K |
| 414 | INKT | MiNK Therapeutics, Inc. | 54.82M | -3.75% | 21,466 | - |
| 415 | OSTX | OS Therapies Incorporated | 54.65M | -3.70% | 535,174 | - |
| 416 | KZR | Kezar Life Sciences, Inc. | 54.33M | 0.27% | 46,038 | - |
| 417 | HYFT | MindWalk Holdings Corp. | 53.14M | -4.46% | 185,724 | 20.70M |
| 418 | MREO | Mereo BioPharma Group plc | 52.51M | 2.81% | 1,167,410 | 500.00K |
| 419 | MGX | Metagenomi Therapeutics, Inc. | 51.92M | -0.72% | 75,909 | 25.21M |
| 420 | ALGS | Aligos Therapeutics, Inc. | 49.47M | 0.69% | 25,432 | 2.19M |
| 421 | XLO | Xilio Therapeutics, Inc. | 49.21M | -0.58% | 12,655 | 43.77M |
| 422 | EDSA | Edesa Biotech, Inc. | 49.05M | -6.76% | 217,420 | - |
| 423 | CUE | Cue Biopharma, Inc. | 49.02M | 71.36% | 232,318,819 | 27.47M |
| 424 | NTRB | Nutriband Inc. | 47.41M | 1.30% | 9,024 | 2.28M |
| 425 | LSTA | Lisata Therapeutics, Inc. | 45.25M | 0.20% | 13,778 | 170.00K |
| 426 | ANVS | Annovis Bio, Inc. | 45.08M | -1.85% | 2,632,141 | - |
| 427 | RLYB | Rallybio Corporation | 44.64M | 1.95% | 29,409 | 858.00K |
| 428 | RNXT | RenovoRx, Inc. | 44.39M | 0.71% | 594,924 | 1.12M |
| 429 | ATOS | Atossa Therapeutics, Inc. | 42.54M | -0.80% | 30,068 | - |
| 430 | LITS | Lite Strategy, Inc. | 42.18M | -0.85% | 227,991 | - |
| 431 | TELO | Telomir Pharmaceuticals, Inc. | 41.94M | -3.17% | 51,925 | - |
| 432 | RNTX | Rein Therapeutics Inc. | 41.78M | -2.61% | 40,248 | - |
| 433 | IMMP | Immutep Limited | 41.78M | -2.52% | 895,206 | 5.28M |
| 434 | NXTC | NextCure, Inc. | 41.44M | 3.84% | 68,517 | - |
| 435 | HYPD | Hyperion DeFi, Inc. | 41.35M | 11.01% | 411,386 | 813.46K |
| 436 | HOWL | Werewolf Therapeutics, Inc. | 41.26M | -5.50% | 208,603 | 1.14M |
| 437 | ACTU | Actuate Therapeutics, Inc. | 40.78M | -8.99% | 56,308 | - |
| 438 | SNSE | Sensei Biotherapeutics, Inc. | 40.06M | -2.10% | 11,866 | - |
| 439 | VERU | Veru Inc. | 38.20M | -3.29% | 21,711 | 16.89M |
| 440 | ATRA | Atara Biotherapeutics, Inc. | 38.03M | -3.73% | 87,055 | 120.77M |
| 441 | CELU | Celularity Inc. | 36.62M | -6.62% | 11,707 | 40.58M |
| 442 | CRVO | CervoMed Inc. | 35.46M | -4.96% | 35,300 | 4.01M |
| 443 | LIXT | Lixte Biotechnology Holdings, Inc. | 35.43M | 5.17% | 129,783 | - |
| 444 | ABVC | ABVC BioPharma, Inc. | 35.33M | - | 95,477 | 797.92K |
| 445 | PTN | Palatin Technologies, Inc. | 34.01M | -1.80% | 6,065 | 8.96M |
| 446 | LGVN | Longeveron Inc. | 33.97M | 4.50% | 792,147 | 1.20M |
| 447 | EVAX | Evaxion A/S | 33.69M | -1.70% | 75,607 | 7.53M |
| 448 | ATNM | Actinium Pharmaceuticals, Inc. | 33.67M | -5.26% | 74,418 | 90.00K |
| 449 | PLUR | Pluri Inc. | 33.37M | -2.06% | 3,216 | 1.34M |
| 450 | CVM | CEL-SCI Corporation | 32.94M | -4.91% | 21,523 | - |
| 451 | PSTV | Plus Therapeutics, Inc. | 32.94M | 22.45% | 1,313,748 | 5.21M |
| 452 | DYAI | Dyadic International, Inc. | 32.46M | 1.71% | 35,491 | 3.09M |
| 453 | PASG | Passage Bio, Inc. | 31.73M | -11.62% | 46,756 | - |
| 454 | INMB | INmune Bio Inc. | 31.37M | -7.81% | 448,196 | 50.00K |
| 455 | BCTX | BriaCell Therapeutics Corp. | 30.73M | -5.73% | 138,986 | - |
| 456 | TPST | Tempest Therapeutics, Inc. | 29.41M | 29.75% | 1,712,842 | - |
| 457 | APLM | Apollomics, Inc. | 29.20M | -8.42% | 99,676 | 6.93M |
| 458 | MRKR | Marker Therapeutics, Inc. | 29.18M | - | 193,882 | 3.55M |
| 459 | KYNB | Kyntra Bio, Inc. | 29.02M | -0.28% | 4,206 | 6.44M |
| 460 | IGC | IGC Pharma, Inc. | 28.93M | 0.30% | 420,861 | 1.11M |
| 461 | TVRD | Tvardi Therapeutics, Inc. | 27.21M | -2.03% | 51,455 | - |
| 462 | SNTI | Senti Biosciences, Inc. | 27.19M | 0.89% | 40,915 | 22.00K |
| 463 | DARE | Daré Bioscience, Inc. | 26.64M | -1.08% | 88,119 | 1.03M |
| 464 | OTLK | Outlook Therapeutics, Inc. | 26.05M | 12.06% | 2,153,949 | 205.70K |
| 465 | NEUP | Neuphoria Therapeutics Inc. | 25.77M | 1.27% | 60,115 | 14.99M |
| 466 | BOLD | Boundless Bio, Inc. | 25.32M | -0.88% | 105,599 | - |
| 467 | NRSN | NeuroSense Therapeutics Ltd. | 24.74M | -4.11% | 94,833 | - |
| 468 | SER | Serina Therapeutics, Inc. | 24.38M | -1.00% | 136,668 | 130.00K |
| 469 | XCUR | Exicure, Inc. | 24.07M | -7.88% | 8,594 | 500.00K |
| 470 | SKYE | Skye Bioscience, Inc. | 24.03M | -0.80% | 79,479 | - |
| 471 | TVGN | Tevogen Bio Holdings Inc. | 23.86M | -2.22% | 26,480 | - |
| 472 | BRNS | Barinthus Biotherapeutics plc | 23.18M | 3.18% | 19,996 | 14.97M |
| 473 | LEXX | Lexaria Bioscience Corp. | 22.65M | 0.56% | 92,919 | 522.00K |
| 474 | JSPR | Jasper Therapeutics, Inc. | 22.46M | -2.59% | 800,918 | - |
| 475 | VTGN | Vistagen Therapeutics, Inc. | 22.20M | 0.81% | 290,258 | 789.00K |
| 476 | LTRN | Lantern Pharma Inc. | 22.08M | 5.35% | 402,094 | - |
| 477 | AEON | AEON Biopharma, Inc. | 21.25M | 1.20% | 26,277 | - |
| 478 | NNVC | NanoViricides, Inc. | 21.22M | -7.29% | 127,998 | - |
| 479 | QNTM | Quantum BioPharma Ltd. | 21.04M | 7.80% | 111,290 | - |
| 480 | VYNE | VYNE Therapeutics Inc. | 20.33M | -0.41% | 101,039 | 570.00K |
| 481 | ALLR | Allarity Therapeutics, Inc. | 20.09M | 10.43% | 288,385 | 320.00K |
| 482 | CRIS | Curis, Inc. | 19.99M | -1.98% | 1,855,046 | 9.44M |
| 483 | CTXR | Citius Pharmaceuticals, Inc. | 18.01M | -4.51% | 290,236 | 3.94M |
| 484 | OSRH | OSR Holdings, Inc. | 17.72M | 4.76% | 1,043,600 | 2.91M |
| 485 | PLRZ | Polyrizon Ltd. | 17.57M | 0.74% | 79,079 | - |
| 486 | KTTA | Pasithea Therapeutics Corp. | 17.46M | -2.78% | 435,567 | - |
| 487 | COCP | Cocrystal Pharma, Inc. | 17.23M | -12.59% | 595,063 | - |
| 488 | LPCN | Lipocine Inc. | 16.06M | 5.26% | 1,320,638 | 1.98M |
| 489 | GNTA | Genenta Science S.p.A. | 15.78M | -1.47% | 31,848 | - |
| 490 | HIND | Vyome Holdings, Inc. | 15.37M | -4.78% | 13,767 | 319.71K |
| 491 | ICU | SeaStar Medical Holding Corporation | 14.82M | -8.62% | 166,211 | 1.23M |
| 492 | JUNS | Jupiter Neurosciences, Inc. | 14.47M | 4.04% | 35,123 | 21.80K |
| 493 | PHIO | Phio Pharmaceuticals Corp. | 14.06M | -3.20% | 188,257 | - |
| 494 | MBRX | Moleculin Biotech, Inc. | 13.98M | 2.75% | 55,098 | - |
| 495 | INTS | Intensity Therapeutics, Inc. | 13.97M | -1.79% | 15,500 | - |
| 496 | INAB | IN8bio, Inc. | 13.69M | -2.80% | 34,727 | - |
| 497 | BCDA | BioCardia, Inc. | 12.91M | 0.85% | 9,016 | 3.00K |
| 498 | KAPA | Kairos Pharma, Ltd. | 12.49M | 4.18% | 28,109 | - |
| 499 | CYCN | Cyclerion Therapeutics, Inc. | 12.30M | -7.91% | 331,966 | 2.07M |
| 500 | CMMB | Chemomab Therapeutics Ltd. | 12.02M | - | 19,822 | - |